NRF2 activation by myeloid cell–derived oxidative stress induces SNAI-driven features of EMT in breast cancer
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2521491123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Mustafa Kaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Tumor Immunology Laboratory, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska…. Hauptthemen laut MEDLINE: Snail Family Transcription Factors, Epithelial-Mesenchymal Transition, Oxidative Stress, Myeloid Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vetenskapsrådet (VR), Cancerfonden (Swedish Cancer Society), Sjöbergstiftelsen (Sjöberg Foundation).
Abstract (Originalsprache)
Metastasis is facilitated by epithelial-to-mesenchymal transition (EMT), a process in which epithelial cancer cells, including breast cancer cells, acquire mesenchymal-like phenotypes. Production of reactive oxygen species (ROS) by NADPH oxidase 2 (NOX2) is a principal inflammatory and antimicrobial feature of myeloid cells. Inflammation has been linked to EMT, but the role of ROS released from tumor-infiltrating myeloid cells in EMT is unknown. In coculture experiments with human or murine myeloid cells and breast cancer cells, we observed that NOX2-derived ROS induced EMT-like changes in MCF-7, T-47D, 4T1, and EO771 cells via activation of SNAI transcription factors, mediated by the ROS-sensitive transcription factor NRF2. Intratumoral administration of the NOX2/ROS-activating peptide WKYMVm to mice carrying orthotopically implanted 4T1 or EO771 tumors increased primary tumor growth, augmented tumor cell expression of EMT markers and aggravated distant metastasis. Effects of ROS released from myeloid cells were mimicked by exogenous hydrogen peroxide (H 2 O 2 ) and reversed by a ROS scavenger or a NOX2 inhibitor. In accordance, myeloid cells from Nox2 -deficient mice were less prone to induce EMT in breast cancer cells in vitro or in vivo. Analysis of publicly available human breast cancer datasets showed correlations between NOX2 and EMT-related gene expression within the tumor microenvironment. Additionally, high expression of NOX2 subunit genes and SNAI1 associated with reduced metastasis-free survival. These findings imply that myeloid cell–derived ROS initiate partial EMT in breast cancer cells to promote dissemination and that strategies to target myeloid cell–derived ROS may be explored to limit metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Tumor Immunology Laboratory, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 41390, Sweden.
- Department of Surgery, Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, University of Gothenburg, Gothenburg 41390, Sweden.
- Department of Biomedical and Translational Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
- Department of Infectious Diseases, Tumor Immunology Laboratory, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 41390, Sweden.
ORCID-Profile: Olivia Johnsson, Nuttida Issdisai, Anushka Dongre, Kristoffer Hellstrand, Anna Martner
Förderung
- Vetenskapsrådet (VR)
- Cancerfonden (Swedish Cancer Society)
- Sjöbergstiftelsen (Sjöberg Foundation)
- Stiftelsen Assar Gabrielssons Fond (AG Fond)
- Stiftelserna Wilhelm och Martina Lundgrens (Wilhelm and Martina Lundgren Foundation)
- Anna-Lisa och Bror Björnssons Stiftelse (Anna-Lisa and Bror Björnsson Foundation)
- ALF Funds at the Sahglrenska University Hospital
Zitieren
APA
Kaya, M., Johnsson, O., Issdisai, N., Paul, S., Wiel, C., Dongre, A., Hellstrand, K., & Martner, A. (2026). NRF2 activation by myeloid cell–derived oxidative stress induces SNAI-driven features of EMT in breast cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2521491123
Vancouver
Kaya M, Johnsson O, Issdisai N, Paul S, Wiel C, Dongre A, et al. NRF2 activation by myeloid cell–derived oxidative stress induces SNAI-driven features of EMT in breast cancer. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2521491123
BibTeX
@article{Kaya2026,
author = {Kaya, Mustafa and Johnsson, Olivia and Issdisai, Nuttida and Paul, Sanchari and Wiel, Clotilde and Dongre, Anushka and Hellstrand, Kristoffer and Martner, Anna},
title = {NRF2 activation by myeloid cell–derived oxidative stress induces SNAI-driven features of EMT in breast cancer},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2521491123}
}
EUVIMED